Cidara Therapeutics, Inc. has raised $240.0M in total funding. The most recent round was Series B.
Cidara Therapeutics, Inc. is headquartered in San Diego, CA.
Merck agreed to acquire the San Diego biotech for approximately $9.2 billion in November 2025.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.